Article
Biologic retention rate and efficacy in patients with cluster-based phenotypes of ankylosing spondylitis: data from a Korean national biologics registry.
Clinical and experimental rheumatology - 1 Sept 2022
Min Hong Ki, Kim Hae-Rim, Lee Sang-Heon, Kang Kwi Young, Park Sung-Hwan, Shin Kishul, Kim Jinhyun, Kwok Seung-Ki
Abstract excerpt
OBJECTIVES: Patients with ankylosing spondylitis (AS) have a heterogenic disease course and treatment response. Cluster-based phenotypes are useful for predicting AS disease course. Here, we compared drug retention and clinical efficacy of biologic disease-modifying anti-rheumatic drugs (bDMARDs) in AS patients with cluster A and cluster B phenotypes. METHODS: AS patients enrolled in the Korean College of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
